eydenzelt boav

Generic: aflibercept

Labeler: celltrion usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name eydenzelt boav
Generic Name aflibercept
Labeler celltrion usa, inc.
Dosage Form INJECTION
Routes
INTRAVITREAL
Active Ingredients

aflibercept 2 mg/.05mL

Manufacturer
CELLTRION USA, Inc.

Identifiers & Regulatory

Product NDC 72606-026
Product ID 72606-026_f6ea0f05-1fa2-496b-bbcc-01713b51f6c1
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761377
Listing Expiration 2026-12-31
Marketing Start 2024-09-26

Pharmacologic Class

Established (EPC)
vascular endothelial growth factor inhibitor [epc]
Mechanism of Action
vascular endothelial growth factor inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72606026
Hyphenated Format 72606-026

Supplemental Identifiers

RxCUI
2725889 2725896 2725899 2725903
UPC
0372606026020 0372606026013
UNII
15C2VL427D
NUI
N0000193543 N0000193542

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name eydenzelt boav (source: ndc)
Generic Name aflibercept (source: ndc)
Application Number BLA761377 (source: ndc)
Routes
INTRAVITREAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/.05mL
source: ndc
Packaging
  • 1 SYRINGE, PLASTIC in 1 CARTON (72606-026-01) / .05 mL in 1 SYRINGE, PLASTIC
  • 1 VIAL, SINGLE-USE in 1 CARTON (72606-026-02) / .05 mL in 1 VIAL, SINGLE-USE
source: ndc

Packages (2)

72606-026-01 1 SYRINGE, PLASTIC in 1 CARTON (72606-026-01) / .05 mL in 1 SYRINGE, PLASTIC 72606-026-02 1 VIAL, SINGLE-USE in 1 CARTON (72606-026-02) / .05 mL in 1 VIAL, SINGLE-USE

Ingredients (1)

aflibercept (2 mg/.05mL)

Linked Drug Pages (1)

EYDENZELT boav ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVITREAL"], "spl_id": "f6ea0f05-1fa2-496b-bbcc-01713b51f6c1", "openfda": {"nui": ["N0000193543", "N0000193542"], "upc": ["0372606026020", "0372606026013"], "unii": ["15C2VL427D"], "rxcui": ["2725889", "2725896", "2725899", "2725903"], "spl_set_id": ["7dd4c4da-fe59-4208-927d-7e7965bd7d69"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "pharm_class_moa": ["Vascular Endothelial Growth Factor Inhibitors [MoA]"], "manufacturer_name": ["CELLTRION USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, PLASTIC in 1 CARTON (72606-026-01)  / .05 mL in 1 SYRINGE, PLASTIC", "package_ndc": "72606-026-01", "marketing_start_date": "20240926"}, {"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (72606-026-02)  / .05 mL in 1 VIAL, SINGLE-USE", "package_ndc": "72606-026-02", "marketing_start_date": "20240926"}], "brand_name": "EYDENZELT boav", "product_id": "72606-026_f6ea0f05-1fa2-496b-bbcc-01713b51f6c1", "dosage_form": "INJECTION", "pharm_class": ["Vascular Endothelial Growth Factor Inhibitor [EPC]", "Vascular Endothelial Growth Factor Inhibitors [MoA]"], "product_ndc": "72606-026", "generic_name": "aflibercept", "labeler_name": "CELLTRION USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EYDENZELT", "brand_name_suffix": "boav", "active_ingredients": [{"name": "AFLIBERCEPT", "strength": "2 mg/.05mL"}], "application_number": "BLA761377", "marketing_category": "BLA", "marketing_start_date": "20240926", "listing_expiration_date": "20261231"}